The dose for Prolia is one prefilled syringe administered by a healthcare ... They are both given as a subcutaneous injection ...

As part of the agreement, Celltrion acknowledged that the denosumab patents it challenged were valid and infringed by the company’s biosimilar candidates in the U.S. The settlement appears to ...